Corvus Pharmaceuticals Email Format

Biotechnology ResearchCalifornia, United States11-50 Employees

Corvus Pharmaceuticals is a clinical-stage biotechnology company based in Burlingame, California, focused on developing therapeutics with the potential to impact cancer and immune-related diseases. The organization emphasizes a collaborative, community-based culture that supports open communication and cross-disciplinary learning among a relatively small team. In its stated focus, the company pursues programs addressing oncology and autoimmune/inflammatory conditions within the biotechnology research landscape. 

Most recently, Andrew C. Chan, M.D., Ph.D., joined the board of directors, effective April 23, 2026. The company operates within the biotechnology sector as a clinical-stage enterprise and maintains governance updates as part of its ongoing leadership evolution.

Sign up for free to view info

Company overview Employee directory